IQVIA Asia-Pacific — Revenue decreased by 6.8% to $812.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.8%, from $798.00M to $812.00M. Over 4 years (FY 2021 to FY 2025), Asia-Pacific — Revenue shows an upward trend with a 6.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growing demand for healthcare data and clinical research services in the region, while a decrease may signal heightened competition or economic headwinds in local markets.
This metric represents the total gross income generated by the company's operations within the Asia-Pacific geographic r...
Peers in the CRO and healthcare analytics space typically report regional revenues to demonstrate geographic diversification and emerging market exposure.
iqv_segment_asia_pacific_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $668.00M | $689.00M | $697.00M | $701.00M | $756.00M | $734.00M | $805.00M | $757.00M | $791.00M | $791.00M | $634.00M | $778.00M | $773.00M | $771.00M | $807.00M | $798.00M | $841.00M | $870.00M | $871.00M | $812.00M |
| QoQ Change | — | +3.1% | +1.2% | +0.6% | +7.8% | -2.9% | +9.7% | -6.0% | +4.5% | +0.0% | -19.8% | +22.7% | -0.6% | -0.3% | +4.7% | -1.1% | +5.4% | +3.4% | +0.1% | -6.8% |
| YoY Change | — | — | — | — | +13.2% | +6.5% | +15.5% | +8.0% | +4.6% | +7.8% | -21.2% | +2.8% | -2.3% | -2.5% | +27.3% | +2.6% | +8.8% | +12.8% | +7.9% | +1.8% |